Navigation Links
Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
Date:8/21/2012

BOSTON, Aug. 21, 2012 /PRNewswire/ -- Sequence, Inc. and PCI, LLC, leaders in the fields of regulatory compliance and pharmaceutical calibration respectively, have announced the collaborative opening of a new office in the Innovation District of Boston, Massachusetts.

Establishing a Boston office provides Sequence and PCI an opportunity to extend service offerings to new and existing clients in the New England biotech and pharmaceutical sectors. "The coupling of validation and calibration services presents our clients with a streamlined approach to quality. It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike.  We are proud to partner with PCI, a firm well known as the distinguished leader in calibration services," said Mike Putnam, President of Sequence, Inc.

"For some time now, a New England presence has been a key part of our expansion plans," said Andy Ferrell, President of PCI. "We believe our services will be of great value to this region's life science community. Partnering with a validation firm that has high moral standards and values similar to ours is very attractive. We look forward to partnering with Sequence, Inc. and see this as a great opportunity for our firms to offer comprehensive, highly valued service solutions."

About Sequence, Inc.

Sequence, Inc. is proud to be celebrating its ten-year anniversary of providing validation and regulatory compliance services to the life sciences industry. Our areas of expertise include validation of laboratory instruments, information systems, and manufacturing equipment/processes as well as quality remediation, system configuration, and project management. We take pride in developing partner-like relationships with our clients and view employees as our most valuable asset.

About PCI, LLC.

PCI specializes in delivering instrument and equipment solutions that will reduce costs and enhance operational efficiencies while improving the compliance. Since 1996, our mission has been to provide personalized customer service, exceptional technical expertise, quality documentation and the integrity and ingenuity that our clients have grown to expect from the industry leader in calibration services.

For further information, visit www.sequencevalidation.com or email info@sequencevalidation.com for Sequence, Inc. and visit www.pci-llc.com or email PCI@pci-llc.com for PCI, LLC.

Contact:

Sequence, Inc.
Mike Putnam
919-844-7171

PCI, LLC
Andy Ferrell, President 
877-724-2257

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Sequence, Inc.; PCI, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... PUNE, India , December 5, 2016 /PRNewswire/ ... Market Research, titled, "Global Cancer Biomarkers Market - Global Opportunity ... biomarkers market is projected to reach $15,737 million by 2022 ... from 2016 to 2022. Omic technologies segment accounted for more ... expected to maintain its dominance during the forecast period. ...
(Date:12/5/2016)... --  TrainerMD , the first HIPAA compliant software collaboration platform for ... Styku . Styku, a California -based ... users world-class, real-time 3D body scanning and analysis. Together with its ... hear and feel their health like never before. ... , , ...
(Date:12/5/2016)...  CVS Health, the nation,s largest pharmacy innovation company, ... of 100 percent on the Corporate Equality Index (CEI) ... annual national benchmarking survey and report on corporate policies ... Human Rights Campaign Foundation. "Our company,s ... customers and suppliers bring to CVS Health," said ...
Breaking Medicine Technology:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the launch of a Kickstarter crowd funding campaign ( http://kck.st/2g3a1so ) for the ... active alerts and even taking an EKG from the watch while sharing these ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... to understand the scope of their EHS regulatory obligations and rapidly collect, share, ...
(Date:12/5/2016)... Angeles (PRWEB) , ... December 05, 2016 , ... What: ... feed of the North Pole to our patients – using a video monitor and ... video. The hospital will transform the Auditorium into a Christmas Wonderland, which is where ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
Breaking Medicine News(10 mins):